Public Meeting
BioPharma Congress
Monday, February 26th, 2024
Time: 8:00 AM EST – 1:00PM EST
Ritz-Carlton
1150 22nd St NW, Washington, DC 20037
This event is hosted by Prevision Policy and Friends of Cancer Research (Friends).
Agenda
FDA OCE Reunion
- Richard Pazdur, U.S. FDA Oncology Center of Excellence
- Amy McKee, Parexel Oncology Center of Excellence
- Julia Beaver, Treeline Biosciences
- Geoffrey Kim, PI Health
- Gideon Blumenthal, Merck
CBER 2024 Priorities
- Peter Marks, U.S. FDA Center for Biologics Evaluation and Research
FDA Then and Now
- Janet Woodcock, U.S. FDA
Advisory Committees: What Does It All Mean?
- Richard Pazdur, U.S. FDA Oncology Center of Excellence
- Peter Stein, U.S. FDA Office of New Drugs
IRA Update: Lessons Learned & Looking Ahead
- Coming Soon
